Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Glenmark Pharmaceuticals Ltd

NSE: GLENMARK · BSE: 532296 · Pharmaceuticals & Biotechnology · 39 announcements

Glenmark Pharmaceuticals Ltd news stories on ALFA NewsRead the news →
Share price
₹2,293.50
Market cap
₹64,728 Cr
Revenue (annual)
₹16,983 Cr
Net profit (annual)
₹1,362 Cr
P/E (TTM)
36.0×Sector 47.4×
Promoter holding
46.65%+0.00% QoQ
FII holding
20.89%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

20:42 IST BSE
Management Change

Glenmark Pharmaceuticals Management Change

Glenmark Pharmaceuticals appointed Ms. Rashmi Khandelwal as Company Secretary following Mr. Harish Kuber's retirement. Ms. Khandelwal brings 17 years of corporate governance experience to the role.